16 December 2020

The Pfizer/BioNTech COVID-19 vaccine is authorised for use and rolling out across the UK. We've developed some guidance for rheumatology professionals, based on advice from the Joint Committee of Vaccination and Immunisation (JCVI), which we'll update regularly.

In our guidance, we answer questions including:

  • Who receives the vaccine first?

  • Should immunosuppressed patients receive the vaccine?

  • Should rheumatology treatment be paused or changed?

  • What impact does rituximab treatment have on the vaccine?

  • Should children and young people receive the vaccine?

Read the guidance